ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $249,180 | -29.5% | 254,265 | 0.0% | 0.01% | -37.5% |
| Q2 2023 | $353,428 | +87382.2% | 254,265 | 0.0% | 0.02% | +6.7% |
| Q1 2023 | $404 | -74.5% | 254,265 | 0.0% | 0.02% | -65.9% |
| Q4 2022 | $1,584 | -99.9% | 254,265 | -39.4% | 0.04% | +10.0% |
| Q3 2022 | $2,813,000 | +5.3% | 419,918 | 0.0% | 0.04% | -34.4% |
| Q2 2022 | $2,671,000 | +37.1% | 419,918 | 0.0% | 0.06% | +35.6% |
| Q1 2022 | $1,948,000 | +12.7% | 419,918 | +21.5% | 0.04% | +18.4% |
| Q4 2021 | $1,728,000 | +57.5% | 345,595 | +1012.5% | 0.04% | +137.5% |
| Q1 2017 | $1,097,000 | +564.8% | 31,064 | +159.4% | 0.02% | +433.3% |
| Q3 2016 | $165,000 | -97.0% | 11,976 | -94.9% | 0.00% | -96.5% |
| Q3 2015 | $5,583,000 | -36.2% | 236,669 | +150.4% | 0.09% | -28.9% |
| Q1 2015 | $8,754,000 | – | 94,527 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |